Heru

Heru is a legitimate, high-traction medical technology company (Series A, ~$36M funding) originating from the Bascom Palmer Eye Institute. External verification confirms over 1 million patient exams conducted using its AI/AR vision diagnostic platform. However, the submission itself contained significant inaccuracies (e.g., claiming 'most people' as users and 'everyone' as the audience) and low-quality data. Consequently, while the Real-World Utility and Innovation scores are high based on the actual technology, the Evidence of Traction and Response Quality metrics were heavily penalized for the poor submission data.